← Open Payments lookup

NPI 1306012026: Open Payments

NPI 1306012026. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$301 in 12 payments from 10 companies in 2025. Trend: 2023 $319 · 2024 $158 · 2025 $301

Food & beverage: $201Education: $100
CompanyPaymentsAmount
Astellas Pharma US Inc1$100
Sage Therapeutics, LLC2$36
Exeltis, USA Inc.2$31
Organon LLC1$24
Lilly USA, LLC1$21
PFIZER INC.1$20
Bayer Healthcare Pharmaceuticals Inc.1$20
Exact Sciences Corporation1$17
Supernus Pharmaceuticals, Inc.1$16
VERTEX PHARMACEUTICALS INCORPORATED1$15

Products named: ZURZUVAE, SLYND, NEXPLANON, ZEPBOUND, ABRYSVO, Mirena, The Cologuard Plus Collection Kit, Qelbree.